Skip Navigation

Meet the Staff

Many patients in the Pulmonary Hypertension Program are referred to us by their primary care physicians, cardiologists or pulmonologists, and generally have already been through a battery of tests. We work with referring physicians to track down the results of these tests to avoid any repetition, if possible. Most new patients are seen within a month, while emergent cases are scheduled for a consultation within one to two weeks.

Our physicians are leaders in the field of pulmonary hypertension, and possess vast knowledge and resources that support their passion for excellent patient care. Our dedicated nurse clinicians provide personalized service by following up with patients on a routine basis to talk about medications, any adjustments needed and general well being.

Vallerie V. McLaughlin, M.D.

Dr. McLaughlin

Dr. McLaughlin is a Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Michigan, Ann Arbor, and attending physician at the University of Michigan Medical Center. She is a Fellow of the American College of Cardiology, the American College of Chest Physicians and the American Heart Association, and member of the American Thoracic Society. She has served as Chairman of the American Heart Association “Women in Cardiology” Committee and is a member of the American College of Cardiology Scientific Sessions Program Committee. Dr. McLaughlin is Chair of the Scientific Leadership Council of the Pulmonary Hypertension Association and immediate past Editor-in-Chief of Advances in Pulmonary Hypertension, the official journal of the Pulmonary Hypertension Association. She is Chair of the American College of Cardiology/American Heart Association Clinical Expert Consensus Document on Pulmonary Hypertension. Dr. McLaughlin’s research interests focus on pulmonary hypertension.

Melvyn Rubenfire, M.D. , FACP , FACC , FACCP

Dr. Rubenfire

Dr. Rubenfire is a Professor of Internal Medicine at the University of Michigan. He is a clinical cardiologist and Director of Preventive Cardiology, whose clinical and research interests have been coronary risk assessment and treatment, and alternatives for enhancing quality of life and reducing morbidity and mortality in coronary disease. His present research emphasis is the impact of life style modification and psychological distress in patients with CAD and the metabolic syndrome. Dr. Rubenfire developed the Pulmonary Hypertension Program at the University in 1993 and has extensive clinical and research experience in diagnosis, risk stratification, and treatment paradigms in pulmonary hypertension.

 

Janice Norville

Janice Norville, MSN, MSBA, RN

Janice joined the University of Michigan Health System in 2005. Her clinical background was primarily in med/surg & peri-operative care areas. Janice spent 17 years of her career in these areas at William Beaumont Hospital in Royal Oak. She currently leads the Cardiovascular Medicine Special Programs Teams with programs at the CVC, Dominos and Briarwood. She is the Director of Clinical Operations for the HF Telemanagement Team, the HFT Inpatient NP/PA Service, the Pre & Post Heart Transplant Program, the CVM NP Bridge Clinics, the Adult Congenital Heart Program, the Pulmonary Hypertension Program, the NP’s in the Chest Pain Center in the ED, the CVM at Dominos Farms and BW5 Programs, and the Anticoagulation Program.

Your Pulmonary Hypertension Care Team

Marsha Burks, RN
Lori Shope, RN
Laura Sonntag